MDMengzhu Dong

Mengzhu Dong

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mengzhu Dong has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Chang Liu

    Institute of Animal Husbandry and Veterinary Medicine, Beijing Academy of Agriculture and Forestry Sciences, Beijing 100089, China

    2 shared publications
  • Haijun Jiang

    Institute of Animal Husbandry and Veterinary Medicine, Beijing Academy of Agriculture and Forestry Sciences, Beijing 100089, China

    2 shared publications
  • Ruihan Shi

    Institute of Animal Husbandry and Veterinary Medicine, Beijing Academy of Agriculture and Forestry Sciences, Beijing 100089, China

    2 shared publications
  • Rujun Ye

    Institute of Animal Husbandry and Veterinary Medicine, Beijing Academy of Agriculture and Forestry Sciences, Beijing 100089, China

    2 shared publications
  • Tingwen Zheng

    Institute of Animal Husbandry and Veterinary Medicine, Beijing Academy of Agriculture and Forestry Sciences, Beijing 100089, China

    2 shared publications
  • Yu Zhou

    Institute of Animal Husbandry and Veterinary Medicine, Beijing Academy of Agriculture and Forestry Sciences, Beijing 100089, China

    2 shared publications

Latest Publications

  • Open Access

    Immunization Dose-Dependent In Vivo Replication Kinetics and Protective Efficacy of the Gene-Deleted Marek’s Disease Vaccine SC9-1

    by Rujun Ye, Ruihan Shi, Haijun Jiang, Chang Liu, Mengzhu Dong, Hairong Tian, Tingwen Zheng, Yu Zhou

    In this study, we evaluated the replication kinetics and protective efficacy of the gene-deleted Marek’s disease (MD) vaccine strain SC9-1 in specific-pathogen-free (SPF) chickens immunized with different doses. Chickens were divided into two groups: one group received a high dose (5000 PFU) and the other a low dose (500 PFU) of the vaccine at 1 day of age, with a non-vaccinated group serving as the control. Vaccine viral copy numbers in the spleen and feather tips were detected by quantitative PCR (qPCR) at different days post-vaccination (dpv) (3, 5, 7, 11, and 14 dpv). Meanwhile, a challenge trial was conducted where chickens were challenged with the very virulent Md5 strain (1000 PFU/bird) at 5 dpv and observed until 70 days of age. Results from the vaccination-only experiment revealed that viral replication in the spleen was detectable in 100% of chickens as early as 3 dpv, reaching its peak at 5 dpv, with the high-dose group exhibiting significantly higher viral loads than the low-dose group. In feather tips, replication was detectable in 100% of chickens by 5 dpv and peaked at 7 dpv, but no significant difference was observed between the two dose groups. The unvaccinated control group exhibited 100% mortality with characteristic gross and histopathological lesions of Marek’s disease. In stark contrast, both vaccinated groups (high and low dose) demonstrated 100% survival until the end of the observation period (70 days). No clinical signs or pathological abnormalities were observed in these groups. Furthermore, vaccination with SC9-1 did not adversely impact growth performance and the development of major immune organs, even following subsequent Md5 challenge. The results indicated that a higher initial vaccination dose of the SC9-1 vaccine was associated with elevated peak early in vivo replication level, whereas vaccination dose may not govern viral maturation and shedding levels of SC9-1 in feather-tip tissues. However, peak replication level was not a direct determinant of final protective efficacy. Notably, even the lowest tested dose (500 PFU) afforded full protection against early challenge with a very virulent MDV strain. Collectively, these observations contribute to our understanding of dose-dependent protection induced by gene-deleted MD vaccines and inform rational vaccination strategies.

  • Open Access

    The Development and Evaluation of an SYBR Green I-Based qPCR Assay for Detecting the Marek’s Disease Virus SC9-1 Vaccine Strain

    by Ruihan Shi, Haijun Jiang, Chang Liu, Mengzhu Dong, Tingwen Zheng, Rujun Ye, Yu Zhou

    The increasing virulence of field strains of Marek’s disease virus (MDV), which can overcome the immunity conferred by the widely used CVI988 vaccine, underscores the need for more effective alternatives. The SC9-1 vaccine strain has demonstrated superior protective efficacy and is being increasingly adopted in China. Importantly, it harbors a unique recombinant REV-LTR insertion junction that is absent from all other MDV strains. Targeting this strain-exclusive genomic locus, this study established an SYBR Green I-based quantitative real-time PCR assay for specific detection and quantification of SC9-1 to support clinical vaccine surveillance. We designed specific primers and systematically optimized the qPCR reaction conditions. The resulting assay demonstrated high specificity, showing no cross-reactivity with other MDV strains or common avian pathogens. It achieved a sensitivity of 1.0 × 101 copies/μL, and reproducibility was excellent, with both intra- and inter-assay coefficients of variation below 1.0%. Furthermore, the LOD of this assay for commercial SC9-1 vaccine samples was determined to be 1.22 PFU per 200 μL sample. In conclusion, this SYBR Green I-based qPCR assay provides a specific, sensitive, and reproducible tool for the rapid quantification of the SC9-1 vaccine virus. It is fully validated for routine vaccine quality control, while exhibiting promising potential for subsequent field surveillance within MD vaccination programs.